Prevention and control of infections in patients with severe congenital neutropenia; A follow up study

Iranian Journal of Allergy, Asthma and Immunology

Volumn 11, Issue 1, 2012, Pages 51-56

  Salehi, Tahmineh ^a   Fazlollahi, Mohammad Reza ^a   Maddah, Marzieh ^a   Nayebpour, Mohsen ^b   Yazdi, Mojtaba Tabatabaei ^b   Alizadeh, Zahra ^a   Eshghi, Peyman ^c   Chavoshzadeh, Zahra ^c   Movahedi, Masoud ^a,d   Hamidieh, Amir Ali ^e   Cheraghi, Taher ^f   Pourpak, Zahra ^a,d   Moin, Mostafa ^a,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

GCSF; Immunodeficiency; Neutropenia; Severe congenital neutropenia

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABSOLUTE NEUTROPHIL COUNT; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; APHTHOUS STOMATITIS; ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BLOOD CELL COUNT; BONE MARROW BIOPSY; BONE PAIN; CANCER DIAGNOSIS; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL EXAMINATION; CONTROLLED STUDY; CYTOGENETICS; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; EOSINOPHILIA; EVIDENCE BASED MEDICINE; FATIGUE; FEMALE; FEVER; FOLLOW UP; GINGIVITIS; HEAD AND NECK ABSCESS; HEAD AND NECK DISEASE; HOSPITALIZATION; HUMAN; IMMUNE FUNCTION TEST; INFECTION CONTROL; INFECTION PREVENTION; INJECTION SITE REACTION; LOW DRUG DOSE; LUNG ABSCESS; MALE; MOUTH ULCER; MYELODYSPLASTIC SYNDROME; NEUTROPHIL COUNT; OSTEOMYELITIS; OTITIS; OTITIS MEDIA; PATIENT REFERRAL; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; RISK FACTOR; SCHOOL CHILD; SEPTICEMIA; SEVERE CONGENITAL NEUTROPENIA; SKIN ABSCESS; SPLENOMEGALY; THROMBOCYTOPENIA; TREATMENT DURATION; URINARY TRACT INFECTION;

ADOLESCENT; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; CYTOGENETIC ANALYSIS; DISEASE PROGRESSION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HOSPITALIZATION; HUMANS; IRAN; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; MALE; MYELODYSPLASTIC SYNDROMES; NEUTROPENIA; NEUTROPHILS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84859145542     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Welte K, Zeidler C. Severe congenital neutropenia. Hematol Oncol Clin North Am 2009; 23(2):307-20.
2. Klein C, Welte K. Genetic Insights into Congenital Neutropenia. Clin Rev Allerg Immunol 2010; 38(1):68-7.
3. Ward AC, Dale DC. Genetic and molecular diagnosis of severe congenital neutropenia. Curr Opin Hematol 2009; 16(1):9-13.
4. Liongue C, Wright C, Russell AP, Ward AC. Granulocyte colony-stimulating factor receptor: Stimulating granulopoiesis and much more. Int J Biochem Cell Biol 2009; 41(12):2372-5.
5. Leung TF, Li CK, Kwok KL, Chik KW, Shing MM, Yuen PM. Severe chronic neutropenia inChinese children in Hong Kong J Paediatr Child Health 2001; 37(2):137-41. (Pubitemid 32398092)
6. Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, et al. Severe Chronic Neutropenia: Treatment and Follow-Upof Patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003; 72(2):82-93. (Pubitemid 36164341)
7. James RM, SE Kinsey. The investigation and management of chronic neutropenia in children.Arch Dis Child 2006; 91(10):852-8. (Pubitemid 44521173)
8. Cottle TE, Fier CJ, Donadieu J, Kinsey SE. Risk and benefit oftreatment of severe chronic neutropenia with granulocyte colony-stimulating factor. Semin hematol 2002; 39(2):134-40. (Pubitemid 34298838)
9. Niemeyer CM, Kratz CP. Is granulocyte colony-stimulating factor therapy a risk factor for myelodysplasia/leukemia in patients with congenital neutropenia? Haematologica 2005; 90(1):2-3.
10. Ancliff PJ, Gale RE, Liesner R, Hann I, Linch DC. Longterm follow-up ofgranulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy. Br J Haematol 2003; 120(4):685-90. (Pubitemid 36255871)
11. Zeidler C, Germeshausen M, Klein C, Welte K. Clinical implications ofELA2-, HAX1-, and G-CSF-receptor(CSF3R) mutations in severe congenital neutropenia. Br J Haematol 2009; 144(4):459-67.
12. Zeidler C, Welte K, Barak Y, Barriga F, Bolyard AA, Boxer L, et al. Stem cell transplantation inpatients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000; 95(4):1195-8. (Pubitemid 30099826)
13. Badolato R, Fontana S, Notarangelo LD, Savoldi G. Congenital neutropenia: advances indiagnosis and treatment. Curr Opin Allergy Clin Immunol 2004; 4(6):513-21. (Pubitemid 39573725)
14. Rezaei N, Moin M, Pourpak Z, Ramyar A, Izadyar M, Chavoshzadeh Z. The Clinical, Immunohematological, and Molecular Study of Iranian Patients with Severe Congenital Neutropenia. J Clin Immunol 2007; 27(5):525-33. (Pubitemid 47319259)
15. Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Ramyar A, Moin M, et al. Clinical and Laboratory Findings in Iranian Children with Cyclic Neutropenia. Iran J Allergy Asthma Immunol 2004; 3(1):37-40.
16. Boztug K, Welte K, Zeidler C, Klein C. Congenital Neutropenia Syndromes. Immunol Allergy Clin North Am 2008; 28(2):259-75. (Pubitemid 351522409)
17. Beaupain B, Leblanc T, Reman O, Hermine O, Vannier JP, Suarez F, et al. Is Pegfilgrastim Safe and Effective in Congenital Neutropenia? An Analysisof the French Severe Chronic Neutropenia Registry. Pediatr Blood Cancer 2009; 53(6):1068-73.
18. Shannon K. Reconsidering how wetreat severe congenital neutropenia. Blood 2006; 107(12):4575-6. (Pubitemid 43882592)
19. Donadieu J, Boutard P, Bernatowska E, Tchernia G, Couillaud G, Philippe N, et al. A European phase IIstudy of recombinant human granulocyte colony-stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children. Lenograstim Study Group. Eur J Pediatr 1997; 156(9):693-700. (Pubitemid 27377455)
20. Calderwood S, Kilpatrick L, Douglas SD, Fredddman M, Smith-Whitely K, et al. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood 2001; 97(2):376-82. (Pubitemid 32060320)
21. Sotomatsu M, Kanazawa T, Ogawa C, Watanabe T, Morikawa A. Complication ofrapidly progressive glomerulonephritis in severe congenital neutropenia treated with long-term granulocyte colony-stimulating factor (filgrastim). Br J Haematol 2000; 110(1):234-5. (Pubitemid 30625617)
22. Alizadeh Z, Fazllollahi M, Eshghi P, Hamidieh A, Ghadami M, Pourpak Z. Two cases ofsyndromic neutropenia with a report of novel mutation in G6PC3. Iran J Allergy Asthma Immunol 2011; 10(3):227-30.
23. Dale DC. Recent progress inunderstanding the congenital neutropenia. Curr Opin Hematol 2010; 17(1):1-2.
24. Rosenberg PS, Alter BP, Link DC, Stein S, Rodger E, Bolyard AA, et al. Neutrophil elastase mutations and risk of leukemia in severe congenital neutropenia. Br J Haematol 2008; 140(2):210-3. (Pubitemid 350265043)